·Ö×ÓÉúÎïÑ§ÖØÒª¸ÅÄî½âÊÍ
A
Abundance (mRNA ·á¶È)£ºÖ¸Ã¿¸öϸ°ûÖÐmRNA ·Ö×ÓµÄÊýÄ¿¡£
Abundant mRNA (¸ß·á¶ÈmRNA)£ºÓÉÉÙÁ¿²»Í¬ÖÖÀàmRNA×é³É£¬Ã¿Ò»ÖÖÔÚϸ°ûÖгöÏÖ´óÁ¿¿½±´¡£
Acceptor splicing site (ÊÜÌå¼ôÇÐλµã)£ºÄÚº¬×ÓÓÒÄ©¶ËºÍÏàÁÚÍâÏÔ×Ó×óÄ©¶ËµÄ±ß½ç¡£
Acentric fragment (ÎÞ×ÅË¿Á£Æ¬¶Î)£º(ÓÉ´ò¶Ï²úÉúµÄ)ȾɫÌåÎÞ×ÅË¿Á£Æ¬¶ÎȱÉÙÖÐÐÄÁ££¬´Ó¶øÔÚϸ°û·Ö»¯Öб»¶ªÊ§¡£
Active site (»îÐÔλµã)£ºµ°°×ÖÊÉÏÒ»¸öµ×Îï½áºÏµÄÓÐÏÞÇøÓò¡£
Allele (µÈλ»ùÒò)£ºÔÚȾɫÌåÉÏÕ¼¾Ý¸ø¶¨Î»µã»ùÒòµÄ²»Í¬ÐÎʽ¡£
Allelic exclusion (µÈλ»ùÒòÅųâ)£ºÐÎÈÝÔÚÌØÊâÁܰÍϸ°ûÖÐÖ»ÓÐÒ»¸öµÈλ»ùÒòÀ´±í´ï±àÂëµÄÃâÒßÇòµ°°×ÖÊ¡£
Allosteric control (±ð¹¹µ÷¿Ø)£ºÖ¸µ°°×ÖÊÒ»¸öλµãÉϵķ´Ó¦Äܹ»Ó°ÏìÁíÒ»¸öλµã»îÐÔµÄÄÜÁ¦¡£
Alu-equivalent family (Alu Ï൱ÐòÁлùÒò)£º²¸È鶯Îï»ùÒò×éÉÏÒ»×éÐòÁУ¬ËüÃÇÓëÈËÀàAlu¼Ò×åÏà¹Ø¡£
Alu family (Alu¼Ò×å)£ºÈËÀà»ùÒò×éÖÐһϵÁзÖÉ¢µÄÏà¹ØÐòÁУ¬Ã¿¸öÔ¼300bp³¤¡£Ã¿¸ö³ÉÔ±ÆäÁ½¶ËÓÐAlu Çиîλµã(Ãû×ÖµÄÓÉÀ´)¡£
α-Amanitin(¶ì¸àñû¼î)£ºÊÇÀ´×Ô¶¾Ä¢¹½ Amanita phalloides ¶þ»·°ËëÄ£¬ÄÜÒÖÖÆÕæºËRNA¾ÛºÏø£¬ÌرðÊǾۺÏøII ת¼¡£
Amber codon (çúçêÃÜÂë×Ó)£ººËÜÕËáÈýÁªÌåUAG£¬ÒýÆðµ°°×ÖʺϳÉÖÕÖ¹µÄÈý¸öÃÜÂë×ÓÖ®Ò»¡£
Amber mutation (çúçêÍ»±ä)£ºÖ¸´ú±íµ°°×ÖÊÖа±»ùËáÃÜÂë×ÓÕ¼¾ÝµÄλµãÉÏÍ»±ä³ÉçúçêÃÜÂë×ÓµÄÈκÎDNA ¸Ä±ä¡£
Amber suppressors (çúçêÒÖÖÆ×Ó)£º±àÂëtRNAµÄ»ùÒòÍ»±äʹÆä·´ÃÜÂë×Ó±»¸Ä±ä£¬´Ó¶øÄÜʶ±ðUAG ÃÜÂë×ÓºÍ֮ǰµÄÃÜÂë×Ó¡£
Aminoacyl-tRNA (°±õ£-tRNA)£ºÊÇЯ´ø°±»ùËáµÄתÔËRNA£¬¹²¼ÛÁ¬½ÓλÔÚ°±»ùËáµÄNH2»ùÍźÍtRNA ÖÕÖ¹¼î»ùµÄ3`»òÕß2`-OH »ùÍÅÉÏ¡£
Aminoacyl-tRNA synthetases (°±õ£-tRNA ºÏ³Éø)£º´ß»¯°±»ùËáÓëtRNA 3`»òÕß2`-OH»ùÍŹ²¼ÛÁ¬½ÓµÄø¡£
Amphipathic structure(Á½Ç׽ṹ)£º¾ßÓÐÁ½¸ö±íÃæ£¬Ò»¸öÇ×Ë®£¬Ò»¸öÊèË®¡£Ö¬ÀàÊÇÁ½Ç׽ṹ£¬Ò»¸öµ°°×ÖʽṹÓòÄܹ»ÐγÉÁ½Ç×ÂÝÐý£¬ÓµÓÐÒ»¸ö´øµçµÄ±íÃæºÍÖÐÐÔ±íÃæ¡£
Amplification (À©Ôö)£ºÖ¸²úÉúÒ»¸öȾɫÌåÐòÁжîÍ⿽±´£¬ÒÔȾɫÌåÄÚ»òÕßȾɫÌåÍâDNAÐÎʽ´Ø´æÔÚ¡£
Anchorage dependence (Ìù±ÚÒÀÀµ)£ºÖ¸Õý³£µÄÕæºËϸ°ûÐèÒªÎü¸½±íÃæ²ÅÄÜÔÚÅàÑø»ùÉÏÉú³¤¡£
Aneuploid (·ÇÕû±¶Ìå)£º×é³ÉÓëͨ³£µÄ¶à±¶Ìå½á¹¹²»Í¬£¬È¾É«Ìå»òÕßȾɫÌ寬¶Î»ò³É±¶¶ªÊ§¡£
Annealing (ÍË»ð)£ºÁ½Ìõ»¥²¹µ¥Á´Åä¶ÔÐγÉË«ÂÝÐý½á¹¹¡£
Anterograde (˳ʽתÔË)£ºµ°°×ÖÊÖÊ´ÓÄÚÖÊÍøÑØ×Ÿ߶û»ùÌåÏòÖÊĤתÔË¡£
Antibody (¿¹Ìå)£ºÓÉB ÁܰÍϸ°û²úÉúµÄµ°°×ÖÊ(ÃâÒßÇòµ°°×ÖÊ)£¬ËüÄÜʶ±ðÌØÊâµÄÍâÔ´“¿¹Ô”£¬´Ó¶øÒýÆðÃâÒßÓ¦´ð¡£
Anticoding strand (·´±àÂëÁ´)£ºDNA Ë«Á´ÖÐ×÷ΪĤ°åÖ¸µ¼ÓëÖ®»¥²¹µÄRNA ºÏ³ÉµÄÁ´¡£
Antigen (¿¹Ô)£º½øÈë»ùÌåºóÄÜÒýÆð¿¹Ìå(ÃâÒßÇòµ°°×ÖÊ)ºÏ³ÉµÄ·Ö×Ó¡£
Antiparallel (·´Ê½Æ½ÐÐ)£ºDNAË«ÂÝÐýÒÔÏà·´µÄ·½Ïò×éÖ¯£¬Òò´ËÒ»ÌõÁ´µÄ5`¶ËÓëÁíÒ»ÌõÁ´µÄ3`¶ËÏàÁ¬¡£
Antitermination protein (¿¹ÖÕÖ¹µ°°×ÖÊ)£ºÄܹ»Ê¹RNA¾ÛºÏøͨ¹ýÒ»¶¨µÄÖÕֹλµãµÄµ°°×ÖÊ¡£
AP endonucleases (AP ºËËáÄÚÇÐø)£º¼ôÇеôDNA 5`¶ËÍÑàÑßʺÍÍÑà×à¤Î»µãµÄø
Apoptosis (ϸ°ûµòÍö)£ºÏ¸°û½øÐгÌÐòÐÔËÀÍöµÄÄÜÁ¦£»¶Ô´Ì¼¤Ó¦´ðʹͨ¹ýһϵÁÐÌØ¶¨·´Ó¦´Ý»Ùϸ°ûµÄ;¾¶·¢Éú¡£
Archeae (¹Åϸ¾ú)£º½ø»¯ÖÐÓëԺ˺ÍÕæºË²»Í¬µÄÒ»¸ö·ÖÖ§¡£
Ascue (×ÓÄÒ)£ºÕæ¾úµÄ×ÓÄÒ°üº¬Ëĸö»ò°Ë¸ö(µ¥Ò»µÄ)æß×Ó£¬±íʾһ´Î¼õÊý·ÖÁѵIJúÎï¡£
Att sites (Attλµã)£ºÔÚÊɾúÌåºÍϸ¾úȾɫÌåÖн«ÊɾúÌå²åÈë»òÇгýϸ¾úȾɫÌåµÄλµã¡£
Attenuation (Ë¥¼õ)£º¿ØÖÆÒ»Ð©Ï¸¾úÆô¶¯×Ó±í´ïÖÐÉæ¼°µÄת¼ÖÕÖ¹µ÷¿Ø¡£
Attenuator (Ë¥¼õ×Ó)£ºË¥¼õ·¢Éú´¦µÄÒ»ÖÖÄÚ²¿ÖÕÖ¹×ÓÐòÁС£
Autogenous control (×ÔÌåµ÷¿Ø)£º»ùÒò²úÎï¼õÈõ(¸º×ÔÌåµ÷¿Ø)»òÕß¼¤»î(Õý×ÔÌåµ÷¿Ø)Æä±àÂë»ùÒò±í´ïµÄ×÷Óá£
Autonomous controlling element (×ÔÖ÷¿ØÖÆÔª¼þ)£ºÓñÃ×ÖÐÒ»ÖÖ¾ßÓÐת×ùÄÜÁ¦µÄת×ùÔª¼þ¡£
Autoradiography (·ÅÉäÐÔ×ÓÏÔÓ°)£ºÍ¨¹ý·ÅÉäÐÔ±ê¼Ç·Ö×ÓÔÚ½º¾íÉÏÁôÏÂͼÏñ¼ì²â·Ö×ӵķ½·¨¡£
Autosomes (³£È¾É«Ìå)£º³ýÐÔȾɫÌåÍâµÄËùÓÐȾɫÌå¡£¶þ±¶Ìåϸ°ûÓµÓÐÁ½Ì׳£È¾É«Ìå¡£
B
B lymphocytes or B cell (BÁܰÍϸ°û»òB ϸ°û)£ººÏ³É¿¹ÌåµÄϸ°û¡£
Backcross (»Ø½»)£ºÔÓ½»¼ì²âµÄÁíÒ»ÖÖ(ÔçÆÚµÄ)˵·¨¡£
Back mutation (»Ø¸´Í»±ä)£ºÄæ×ª²úÉú»ùÒòʧ»îЧ¹ûÍ»±äµÄÍ»±ä£¬´Ó¶øÊ¹Ï¸°û»Ö¸´Ò°ÉúÐÍ¡£
Bacteriophage (ϸ¾úÊɾúÌå)£ºÇÖȾϸ¾úµÄ²¡¶¾£¬Í¨³£¼ò³ÆÎªÊɾúÌå¡£
Balbiani ring (B»·)£º¶àÏßȾɫÌåÌõ´øÖÐÒ»¸öºÜ´óµÄÅÝ×´»·¡£
Normal chromosomes (³£È¾É«Ìå)£ºÏà¶Ô½Ï´ó£¬Ò»¶¨ÇøÓòÄÚÔÚÌØ¶¨»¯Ñ§´¦Àíϱ£³Ö×ÅÉ«¡£
Base pair (¼î»ù¶Ô)£ºÊÇDNAË«Á´ÖÐÒ»¶ÔAºÍT »òGºÍC¡£ÔÚRNAÖÐÌØ¶¨Ìõ¼þÏÂÒ²ÄÜÐÎ³ÉÆäËüµÄÅä¶Ô¡£
Bidirectinal replication (Ë«Ïò¸´ÖÆ)£ºµ±Á½¸ö¸´ÖƲæÔÚͬһÆðʼµãÒÔ²»Í¬µÄ·½ÏòÒÆ¶¯Ê±Ðγɡ£
Bivalent (¶þ¼ÛȾɫÌå)£ºÔÚ¼õÊý·ÖÁѳõÆÚÒ»ÖÖ°üÀ¨ËÄÌõȾɫµ¥ÌåµÄ½á¹¹(Á½¸öȾɫµ¥Ìå´ú±íͬԴȾɫÌå)¡£
Blastoderm (ÄÒÅß²ã)£ºÀ¥³æÅßÌ¥·¢ÓýµÄÒ»¸ö½×¶Î£¬ÆäÖÐÅßÌ¥ÖÜΧµÄÒ»²ãϸ°ûºË»òϸ°ûÎ§ÈÆ×ÅÖÐÑëµÄÂѻơ£
Blocked reading frame (±ÕËø¶Á¿ò)£ºÓÉÓÚ±»ÖÕÖ¹ÃÜÂë×Ó´ò¶Ï¶ø²»Äܱ»·Òë³Éµ°°×ÖʵĶÁÂë¿ò¡£
Blunt-end ligation (ƽ¶ËÁ¬½Ó)£ºÖ±½ÓÔÚÄ©¶ËÁ¬½ÓÁ½¸öDNA Ë«Á´·Ö×ӵķ´Ó¦¡£
bp£ºÊǼî»ù¶ÔµÄ¼ò³Æ£¬±íʾDNA Ö®¼äµÄ¾àÀë¡£
Branch migration (·ÖÖ§Ç¨ÒÆ)£ºÖ¸Ë«Á´ÖÐÓëÆä»¥²¹Á´²¿·ÖÅä¶ÔµÄDNAÁ´Í¨¹ýÑÓÉìÓëÆäͬԴµÄ¹Ì¶¨Á´Åä¶ÔµÄÄÜÁ¦¡£
Breakage and reunion (¶ÏÁÑÓëÖØÁ¬)£ºÖ¸Ò»ÖÖÒÅ´«ÖØ×éµÄģʽ£¬ÆäÖÐÁ½¸öDNAË«Á´·Ö×ÓÔÚÏàÓ¦µÄλÖôò¶Ï²¢Ê®×Ö½»²æÖØÐÂÁ¬½Ó(Éæ¼°ÔÚÁ¬½ÓλµãÒìÔ´Ë«Á´µÄÐγÉ)¡£
Buoyant density (Ư¸¡ÃܶÈ)£ººâÁ¿Ò»ÖÖÎïÖÊÆ¯¸¡ÔÚһЩ±ê×¼ÒºÌåÉϵÄÄÜÁ¦£¬ÈçCsCl¡£
C
C banding£ºÔÚ×ÅË¿Á£¸½½ü²úÉú×ÅÉ«ÇøÓòµÄȾɫÌå·Ö´ø¼¼Êõ¡£
C gene (C »ùÒò)£º±àÂëÃâÒßÇòµ°°×ÖÊÁ´ºã¶¨ÇøÓòµÄ»ùÒò¡£
C value (CÖµ)£ºµ¥±¶Ìå»ùÒò×éÖÐDNA µÄ×ÜÁ¿¡£
CAAT box (CAAT ºÐ)£ºÕæºËÉúÎïת¼µ¥Î»ÆðʼµãÉÏÓεı£ÊØÐòÁУ¬±»Ò»×éת¼Òò×Óʶ±ð¡£
Cap (ñ)£ºÊÇÕæºËÉúÎïmRNA 5` ¶ËµÄ½á¹¹£¬ÔÚת¼ºóͨ¹ýÄ©¶Ë5`GTPµÄÁ×Ëá»ùÍźÍmRNAµÄÄ©¶Ë¼î»ù¶øÒýÈë¡£Ôö¼ÓµÄG(ÓÐʱÊÇÆäËü¼î»ù)ÊǼ׻ù»¯µÄ£¬²úÉúÁËMeG5`pppNp… µÄ½á¹¹¡£
CAP(CRP)£ºÓÉcAMP ¼¤»îµÄÕýµ÷¿Øµ°°×ÖÊ¡£¶ÔRNA ¾ÛºÏøÆðʼE.coli ÖÐһЩ²Ù×Ý×Ó(·Ö½â´úл — Ãô¸Ð)ÊDZØÐëµÄ¡£
Capsid (Ò¿Ç)£ºÊDz¡¶¾Î¢Á£ÍⲿµÄµ°°×ÖÊÒ¿ǡ£
Caspases£ºÒ»¸öµ°°×ÖÊø¼Ò×壬Æä³ÉÔ±ÔÚµ÷Íö(ϸ°û³ÌÐòÐÔËÀÍö)ÖÐÆð×÷Óá£
Catabolite repression (·Ö½â´úлÎï×è°)£ºÓÉÓÚÆÏÌÑÌÇÔö¼ÓÒýÆðһЩϸ¾ú²Ù×Ý×Ó±í´ï½µµÍ¡£ÊÇ
cAMP ˮƽ½µµÍʹCAP µ÷¿Øµ°°×ÖÊʧ»îËùµ¼Ö¡£
cDNA£ºÓëRNA »¥²¹µÄµ¥Á´DNA£¬Í¨¹ýÌåÄÚRNA Äæ×ªÂ¼¶øºÏ³É¡£
cDNA clone (cDNA ¿Ë¡)£º´ú±íÒ»¸öRNA µÄË«Á´DNA ½øÈëÒ»¸ö¿ËÂ¡ÔØÌå¡£
Cell cycle (ϸ°ûÖÜÆÚ)£ºÒ»´Îϸ°û·ÖÁѵ½ÁíÒ»´Î·ÖÁѵÄʱÆÚ¡£
Cell hybrid (ϸ°ûÔÓ½»)£º°üº¬À´×Ô²»Í¬ÖÖÊôÇ×±¾Ï¸°ûȾɫÌåµÄÌåϸ°û(ÈçÈË£ÊóÈÚºÏϸ°ûÔÓ½»)£¬Í¨¹ýÈÚºÏϸ°ûÐγÉÈںϵÄÒìÐͺ˶ø²úÉú¡£
Centrioles (ÖÐÐÄÁ£)£ºÔÚ¼õÊý·ÖÁÑÆÚ¾Û¼¯ÔÚÖÐÖḽ½ü¡¢ÓÉ΢¹Ü×é³ÉµÄС¿ÕÔ²ÖùÌ壬λÓÚ×ÅË¿Á£ÉÏ¡£
Centromere (×ÅË¿Á£)£ºÈ¾É«Ìå¾Û¼¯ÇøÓò£¬°üº¬¼õÊý·ÖÁÑ»òÓÐË¿·ÖÁÑ·Ä´¸Ìå½áºÏλµã¡£
Centrosomes (ÖÐÐÄÌå)£º¼õÊý·ÖÁÑϸ°û΢¹Ü×éÖ¯µÄÇøÓò¡£ÔÚ¶¯Îïϸ°ûÖУ¬Ã¿Ò»¸öÖÐÐÄÌå°üÀ¨Ò»¶ÔÓÉ΢¹Ü¸½½ÓµÄ¡¢¸ßÃܶȲ»¶¨ÐÍÇøÓòÎ§ÈÆµÄÖÐÐÄÁ£¹¹³É¡£
Chaperone (·Ö×Ó°éÂÂ)£ºÊ¹Ò»Ð©µ°°×ÖÊ×°±¸»òÕßÇ¡µ±ÕÛµþËùÐèµÄµ°°×ÖÊ£¬µ«ÊÇÕâÖÖµ°°×Öʲ¢²»ÊÇÄ¿±ê¸´ºÏÎïµÄ³É·Ö¡£
Chemical complexity (»¯Ñ§¸´ÔÓ¶È)£º»¯Ñ§·ÖÎö²âÁ¿µÄDNA ³É·ÖÁ¿¡£
Chi sequemce (ChiÐòÁÐ)£ºÒ»¸öÌṩE.coliÖÐRecA ½éµ¼ÒÅ´«ÖØ×éÈȵãµÄ°Ë¾ÛÌåÐòÁС£
Chi structure (Chi½á¹¹)£ºÁ½¸öË«Á´DNAÖ®¼äµÄ½Óͷͨ¹ýÈ¥µôÁ½¸öÁ¬ÔÚÒ»ÆðµÄ»·¶øÊ¹Ã¿¸ö»·²úÉúÏßÐÎÄ©¶Ë±©Â¶³öÀ´¡£ËüÀàËÆÓÚÏ£À°ÎÄchi£¬´Ó¶øµÃ´ËÃû×Ö¡£
Chiasma (½»²æ)£ºÁ½¸öͬԴȾɫÌåÔÚ¼õÊý·ÖÁÑÖн»»»ÎïÖʵÄλµã¡£
Chromatids (Ⱦɫµ¥Ìå)£º¸´ÖÆÊ±²úÉúµÄȾɫÌ忽±´¡£´ËÃû×Öͨ³£ÓÃÀ´ÐÎÈÝ´¦ÓÚËæºóµÄϸ°û·ÖÁÑÆÚËüÃÇ·Ö¿ªµÄ֮ǰµÄȾɫÌå¡£
Chromatin (ȾɫÖÊ)£ºÊÇϸ°ûÖÐÆÚºËÄÚDNAºÍµ°°×Öʸ´ºÏÌå¡£¸ö±ðµÄȾɫÌå²»ÄÜÇø·Ö¿ª¡£ËüÖ»ÄÜͨ¹ýÓëDNA ÌØÒìÐÔ×÷ÓõÄȾÁ϶øÊ¶±ð¡£
Chromatin remodeling (ȾɫÌåÖØ½¨)£ºÖ¸·¢ÉúÔÚ»ùÒò»î»¯×ªÂ¼Ê±ºËСÌåÄÜÁ¿-ÒÀÀµÐ͵ÄÅÅÁлòÖØÅÅ¡£
Chromocenter (ȾɫÖÐÐÄ)£ºÀ´×Ô²»Í¬È¾É«ÌåµÄÒìȾɫÖʾۼ¯¡£
Chromomeres (ȾɫÁ£)£ºÔÚijһʱµÄÆÚȾɫÌåÖУ¬ÌرðÊǼõÊý·ÖÁѳõÆÚ£¬È¾É«ºÜÉîµÄ¿É¼ûС¿ÅÁ££¬´ËʱȾɫÌå¿ÉÄܱíÏÖΪһϵÁеÄȾɫÁ£¡£
Chromosome (ȾɫÌå)£ºÐ¯´øºÜ¶à»ùÒòµÄ»ùÒò×éµÄ·ÖÀ뵥λ¡£Ã¿Ò»ÌõȾɫÌå°üº¬³¤µÄË«Á´DNA ·Ö×ÓÒÔ¼°µÈÁ¿µÄµ°°×ÖÊ¡£Ö»ÔÚϸ°û·ÖÁÑÖвÅΪ¿É¼ûµÄÐÎ̬µ¥Î»¡£
Chromosome walking (ȾɫÌå²½ÒÆ)£ºÁ¬Ðø·ÖÀëЯ´øÖصþDNAÐòÁеĿË¡£¬Ê¹È¾É«Ìå´ó²¿·Ö±»¸²¸Ç¡£²½ÒÆÍ¨³£ÓÃÓÚ»ñµÃij¸ö¸ÐÐËȤµÄλµã¡£
cis-acting locus (˳ʽ×÷ÓÃλµã)£ºÖ»Ó°Ïì´¦ÓÚͬһDNA·Ö×ÓÉϵÄDNAÐòÁУ¬´ËÐÔÖÊͨ³£°µÊ¾¸Ãλµã²»±àÂëµ°°×ÖÊ¡£
cis-acting protein (˳ʽ×÷Óõ°°×ÖÊ)£º²»Í¬Ñ°³£µÄ¡¢Ö»×÷ÓÃÓÚ±í´ïËüµÄDNAÐòÁÐÉϵĵ°°×ÖÊÖÊ¡£
cis configuration (Ë³ÊÆ¹¹ÐÍ)£ºÖ¸ÔÚͬһ¸öDNA ·Ö×ÓÉϵÄÁ½¸öλµã¡£
cis/trans assays(˳/·´²âÑé)£º·ÖÎöÁ½¸öÍ»±äÏà¶Ô¹¹ÐͶԱí´ïµÄÓ°Ï죬˫ÔÓºÏÌåÖУ¬Í¬Ò»»ùÒòÉϵÄÁ½¸öÍ»±äÔÚ·´Ê½¹¹ÐÍÖбíÏÖ³öÍ»±ä±íÐÍ£¬Ë³Êƹ¹ÐÍÖбíÏÖ³öÒ°Éú±íÐÍ¡£
Ciston (˳·´×Ó)£ºÊÇÓÉ˳/·´²âÑ鶨ÒåµÄÒÅ´«µ¥Î»£¬Óë»ùÒòµÈͬ£¬¶¼ÊÇ´ú±íÒ»¸öµ°°×ÖÊÖʵÄDNA µ¥Î»×é³É¡£
Class switching (Àà±ðת»»)£ºÔÚÁܰÍϸ°û·Ö»¯¹ý³ÌÖÐÃâÒßÇòµ°°×ÖÊÖØÁ´C Çø±í´ïµÄת»»¡£
Clone (¿Ë¡)£ºÖ¸´óÁ¿Óë׿ÏÈϸ°ûºÍ·Ö×ÓÏàͬµÄϸ°ûºÍ·Ö×Ó¡£
Cloning vector (¿ËÂ¡ÔØÌå)£ºÐ¯´ø²åÈëÍâԴƬ¶ÎµÄÖÊÁ£»òÊɾúÌ壬´Ó¶ø²úÉú¸ü¶àÎïÖÊ»òµ°°×ÖʲúÎï¡£
Closed reading frame (¹Ø±Õ¶Á¿ò)£º°üº¬×è°Ëü·Òë³Éµ°°×ÖʵÄÖÕÖ¹ÃÜÂë×Ó¡£
Coated vesicles (°ü±»Ä¤ÅÝ)£ºÄ¤±íÃæÓÐÒ»²ãµ°°×ÖÊ£¬ÈçÍø¸ñµ°°×ÖÊ¡¢COP-1¡¢COP-IIµÄĤÅÝ¡£
Coconversion (¹²×ª±ä)£ºÔÚ»ùÒòת»»ÖÐÁ½¸öλµãµÄͬʱÐ޸ġ£
Coding strand (±àÂëÁ´)£ºÓëmRNA ÓÐÏàͬÐòÁеÄDNA Á´¡£
Codominant alleles (¹²ÏÔÐÔµÈλ»ùÒò)£ºÁ½¸ö¶¼¶Ô±íÐÍÓй±Ï×£¬ËÒ²²»Õ¼ÓÅÊÆ¡£
Codon (ÃÜÂë×Ó)£ºÈýÁ¬ÌåºËÜÕËᣬ´ú±íÒ»¸ö°±»ùËá»òÕßÖÕÖ¹Ðźš£
Coevolution (¹²½ø»¯)£º¼ûÐͬ½ø»¯¡£
Cognate tRNAs (ͬ¹¦tRNA)£ºÄܹ»±»Ò»¸öÌØÊâµÄ°±õ£»ù-tRNA ºÏ³Éøʶ±ðµÄtRNA¡£
Coincidental evolution (ÖØºÏ½ø»¯)£º¼ûÐͬ½ø»¯¡£
Cointegrate structure (¹²ºÏ½á¹¹)£ºÁ½¸ö¸´ÖÆ×ÓÈںϲúÉúµÄ½á¹¹£¬Ò»¸ö¸´ÖÆ×Ó´øÓÐÒ»¸öת×ù×Ó£¬ÁíÍâÒ»¸öȱÉÙ£¬µ«ÊÇÕûºÏÌåÖгöÏÖÁ½¸öÔÚ¸´ÖÆ×Ó»ãºÏ´¦µÄת×ù×Ó£¬·½ÏòÊÇÕýÏò¸´ÖÆ¡£
Cold-sensitive (ÀäÃô)£ºÕâÖÖÍ»±äÔÚµÍÎÂÏÂÊÇȱÏÝÐ͵쬵«ÊÇÔÚ¸ßÎÂÏÂÕý³£¡£
Colon hybridization (¾úÂäÔÓ½»)£ºÊ¹ÓÃÔλÔÓ½»À´È·¶¨Ð¯´øÒ»¸öÌØ¶¨Í¬Ô´ÐòÁеIJåÈëDNA
Ƭ¶ÎÔØÌåµÄ¼¼Êõ¡£
Compatibility group (ÏàÈÝ×é)£ºº¬Óв»ÄÜͬʱ´æÔÚÒ»¸öϸ¾úϸ°ûÄÚµÄÖÊÁ£¡£
Complementation (»¥²¹)£º²»Í¬µÄ(·ÇµÈλ)»ùÒòÌṩÀ©É¢ÐͲúÎ´Ó¶øÊ¹º¬ÓÐÁ½¸ö·´Ê½Í»±äµÄÔÓºÏÌå²úÉúÒ°Éú±íÐ͵ÄÄÜÁ¦¡£
Complementation assay (»¥²¹²âÑé)£º¼ûÌåÄÚ»¥²¹²âÑé¡£
Complementation group (»¥²¹Èº)£º»¥Ïà·´Ê½ÖØ×éʱ²»»¥²¹µÄһϵÁÐÍ»±ä£¬Ëü¶¨ÒåÁËÒ»¸öÒÅ´«µ¥Î»(˳·´×Ó)¡£
Complex locus(¸´ºÏ»ùÒò×ù)£º¹ûÓ¬ÖÐÓµÓÐÓë´ú±íµ¥¸öµ°°×ÖʵĻùÒò¹¦Äܲ»Ò»ÖµÄÒÅ´«ÐÔÖÊ¡£ÔÚ·Ö×ÓˮƽÉϸ´ºÏ»ùÒò×ùͨ³£ºÜ´ó(>100kb)¡£
Complexity (¸´ÔÓ¶È)£ºÔÚ¸ø¶¨Ñù±¾Öв»Í¬DNA ÐòÁеÄ×ܳ¤¶È¡£
Composite transposons (¸´ºÏת×ù×Ó)£ºÁ½¸ö²åÈëÐòÁаüΧ×ÅÒ»¶ÎÖÐÑëÇøÓò£¬ÕâÁ½¸öÐòÁÐÖеÄÒ»¸ö»òÕßÁ½¸ö¿ÉÄÜʹÕû¸öÔª¼þת×ù¡£
·Ö×ÓÉúÎïÑ§ÖØÒª¸ÅÄî½âÊÍ
±¾Õ¾Ð¡±à ÍøÂç×ÊÔ´/2015-07-08
Ïà¹Ø»°Ìâ/·Ö×ÓÉúÎïѧ
Î人´óѧ·Ö×ÓÉúÎïѧÌâ¿â
GLOSSARY Abundance of an mRNA is the average number of molecules per cell. Abundant mRNAs consist of a small number of individual species, each present in a large number of copies per cell. Acceptor splicing sitesee right splicing junction. Acentric fragment of a chromosome (generated by ...öλÔÓéÀֵǼÈë¿ÚÏÂÔØ¿ÎöλÔÓéÀÖ¹Ù·½appÏÂÔØöλÔÓéÀÖ¹Ù·½appÏÂÔØ ±¾Õ¾Ð¡±à Ãâ·ÑöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2015-06-21Õã½´óѧ2013-2014·Ö×ÓÉúÎïѧöλÔÓéÀֵǼÈë¿ÚÏÂÔØöλÔÓéÀÖ¹Ù·½appÏÂÔØÕæÌâ»ØÒä
Í¿öÎèº 2012¼¶ÉúÎï¿ÆÑ§ 2013-2014 ·Ö×ÓÉúÎïѧ¼× »ØÒä Ò»¡¢·Ò루25Ñ¡20£© Nucleosome Telomerase Deoxyribonucleic Acid Ribosome In vivo Eukaryote Transcrption Reconbination PTGS Epigenetics SnRNP RNAi ³ÁĬ¸´ºÏÌå ͬβø ת¼ºó»ùÒò³ÁĬ µ°°×ÖÊ×éѧ ¹¦ÄÜ»ùÒò×éѧ Ó«¹â¹²ÕñÄÜÁ¿´«µÝ ¿ª·ÅÔĶÁ¿ò ...öλÔÓéÀֵǼÈë¿ÚÏÂÔØ¿ÎöλÔÓéÀÖ¹Ù·½appÏÂÔØöλÔÓéÀÖ¹Ù·½appÏÂÔØ ±¾Õ¾Ð¡±à Ãâ·ÑöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2015-06-06ºÓÄϹ¤Òµ´óѧ2006-2007·Ö×ÓÉúÎïѧÆÚÄ©öλÔÓéÀֵǼÈë¿ÚÏÂÔØÊÔ¾í
öλÔÓéÀֵǼÈë¿ÚÏÂÔØ¿ÎöλÔÓéÀÖ¹Ù·½appÏÂÔØöλÔÓéÀÖ¹Ù·½appÏÂÔØ ±¾Õ¾Ð¡±à Ãâ·ÑöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2015-06-052015ÄêÖÐÔºöλÔÓéÀÖ¹Ù·½appÏÂÔØÕæÌâ_612ÉúÎﻯѧÓë·Ö×ÓÉúÎïѧ
2015Öйú¿ÆÑ§Ôº´óѧ¡¶Éú»¯Óë·Ö×ÓÉúÎï¡· Ò»Ãû´Ê½âÊÍ£¨5*4£© Á÷¶¯ÏâǶģÐÍ Ìǽͽâ ϸ°ûºôÎü ÑϽô¿ØÖÆ Ð¡·Ö×Ó¸ÉÈÅRNA ¶þµ¥Ñ¡£¨1*20£© ¿´ÆðÀ´ºÃÏñ²»ÄÑ£¬µ«ÊÇÏÝÚåÂù¶à¡£ËùνÖпÆÔºµÄÌâÆ«£¬»ù±¾É϶¼Æ«ÔÚÕâÀϲ»¶¿¼Ð©ÁãÁãËéËéµÄ¡£ ÈýÅжÏÌ⣨1*30£© Õⲿ·Ö²Î¿¼Ò»ÏÂÀúÄêÕæÌ⣬¾ÓÈ»ÓÖÓÐÖØ¸´ Ëļò´ðÌâ 1¡¢ ϸ°ûĤÔÚ´úлµ÷ ...öλÔÓéÀֵǼÈë¿ÚÏÂÔØ¿ÎöλÔÓéÀÖ¹Ù·½appÏÂÔØöλÔÓéÀÖ¹Ù·½appÏÂÔØ ±¾Õ¾Ð¡±à Ãâ·ÑöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2015-05-30»ª¿ÆÉúÎﻯѧÓë·Ö×ÓÉúÎïѧöλÔÓéÀÖ¹Ù·½appÏÂÔØöλÔÓéÀÖ¹Ù·½appÏÂÔØ
Ãû´Ê½âÊÍ£ºÏ¸°ûÖÜÆÚ£ºÕæºËϸ°ûÖ÷ÒªÒÔÓÐË¿·ÖÁѵķ½Ê½½øÐÐÔöÖ³¡£½øÈëÔöÖ³µÄϸ°û£¬Í¨¹ýһϵÁÐÑ»··¢ÉúµÄʼþ£¬×îÖÕʵÏÖϸ°û·ÖÁÑ£¬²úÉúÁ½¸ö×Ó´úϸ°û£¬ÕâÒ»¹ý³Ì±»³ÆÎªÏ¸°ûÖÜÆÚ¡£CDK:ÖÜÆÚµ°°×ÒÀÀµÐÔµ°°×¼¤Ã¸(cyclin-dependent protein kinases, Cdks)Ö÷ÒªÔÚϸ°ûÖÜÆÚµ÷¿ØÖÐÆð×÷Óõĵ°°×¼¤Ã¸£¬ÓÉÓÚÊÜÖÜÆÚµ°°×µÄ¼¤»î¶øµÃÃû¡£Cyclin£º ...öλÔÓéÀֵǼÈë¿ÚÏÂÔØ¿ÎöλÔÓéÀÖ¹Ù·½appÏÂÔØöλÔÓéÀÖ¹Ù·½appÏÂÔØ ±¾Õ¾Ð¡±à Ãâ·ÑöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2015-04-24·Ö×ÓÉúÎïѧ¸¨µ¼±Ê¼Ç
£¨Ç°4ÕÂ×¢Òâ¸ÅÄî¾ÍÐÐÁË£¬ÖصãÊÇת×ù×Ó£¬RNA±à¼£©Chapter1ÕæºËÉúÎï»ùÒò×é½á¹¹Ó빦ÄܵÄÌØµã±¾ÕÂÓ¦ÕÆÎյĻù±¾¸ÅÄîϸ°ûºË»ùÒò×éµÄ´óС£»Cֵì¶Ü£»Öظ´ÐòÁУ»»ùÒò¼Ò×壻տºË»ùÒòµÄ¶ÏÁѽṹ »ùÒò¼Ò×壨gene family) Ö¸ºËÜÕËáÐòÁлò±àÂë²úÎïµÄ½á¹¹¾ßÓÐÒ»¶¨³Ì¶ÈͬԴÐÔµÄÒ»×é»ùÒò¡£ ¼Ù»ùÒò£¨pseudoge ...ÉúÎïҽѧ±Ê¼Ç ±¾Õ¾Ð¡±à Ãâ·ÑöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2015-04-13ͬ¼Ã´óѧ2012ÄêÉúÎﻯѧºÍ·Ö×ÓÉúÎïÑ§ÕæÌâ
2012ÄêÉúÎﻯѧºÍ·Ö×ÓÉúÎïÑ§ÕæÌâ Ò»¡¢Ãû´Ê½âÊÍ Á×Ëá¸ÊÓÍ´©Ëó Ë¥¼õ×Ó Ñõ»¯ Á×ËáÎìÌÇ;¾¶ Ñõ»¯Á×Ëữ ת»¯ ħ°ß cori cycle ÄòËØÑ»· gene knock out ¶þ¡¢Ìî¿Õ 1¡¢Ñªºìµ°°×ÓëÑõÆø½áºÏ¾ßÓÐ____ 2¡¢¢òÐÍÄÚº¬×ÓÓëø´Ù¼ô½ÓÄÚº¬×ÓµÄÁ½¸ö¹²Í¬µãÊÇ¡¢___ 3¡¢5ATGAATGCA---3»¥²¹µÄmRNAÊÇ4¡¢NH3¶Ô²¸È鶯Îïϸ°ûÓꦵÄÔÒòÊÇ___ 5¡¢ÕæºËϸ°ûÖУ¬TCAÑ»·ÖÐΨһǶÈëµ½ÏßÁ£ÌåÄÚĤµÄøÊÇ___ 6¡¢Ã¸Ë«µ¹Êý×÷ͼÖУ¬Ö»¸Ä±äбÂʲ»¸Ä±ä×ÝÖá½Ø¾àµÄ×÷Óà 7¡¢¸Î¡¢ÉöÖа±»ùËáÍѰ±»ù·½Ê½£¬¼¡ÈâÖз½Ê½___ 8¡¢ÌǽͽâÖÐΨһÍÑÇâ·´Ó¦___ 9¡¢Ï¡ÓкËÜÕËáÖ÷Òª´æÔÚÓÚ___ 10¡¢ÒÒõ£¸¨Ã¸AºÏ³Éµ¨¹Ì´¼µÄÏÞËÙø11¡¢RNA±à ...öλÔÓéÀֵǼÈë¿ÚÏÂÔØ¿ÎöλÔÓéÀÖ¹Ù·½appÏÂÔØöλÔÓéÀÖ¹Ù·½appÏÂÔØ ±¾Õ¾Ð¡±à Ãâ·ÑöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2015-03-102014Ä껪¶«Ê¦·¶´óѧÉúÎﻯѧÓë·Ö×ÓÉúÎïѧöλÔÓéÀֵǼÈë¿ÚÏÂÔØÑо¿Éúµ÷¼Á
2014Ä껪¶«Ê¦·¶´óѧÉúÎﻯѧÓë·Ö×ÓÉúÎïѧöλÔÓéÀֵǼÈë¿ÚÏÂÔØÑо¿Éúµ÷¼Á¡¡¡¡»ª¶«Ê¦·¶´óѧÊǽÌÓý²¿211¹¤³ÌºÍ985ÖØµãÖ§³ÖµÄ´óѧ¡£ÉúÃüҽѧÑо¿Ëù¼¯ÖÐÁË»ª¶«Ê¦·¶´óѧÉúÃü¿ÆÑ§Ñо¿µÄÏà¹ØÈ˲Å×ÊÔ´ºÍÓÅÊÆÑо¿Á¦Á¿£¬ÌرðÎüÒýÁËÒ»Åú´Óº£Íâ¹éÀ´µÄÉúÎïҽѧ½çÓÅÐãÈ˲š£´ÓÈ«Çò·¶Î§ÄÚÒý½ø¸ß²ã´ÎÈ˲ţ¬½¨Á¢³ÉÒ»Ö§¸ßˮƽµÄÑо¿ÍŶӡ£»ù±¾ÐγÉÒÔ ...öλÔÓéÀÖ¹Ù·½appÏÂÔØµ÷¼ÁÐÅÏ¢ ±¾Õ¾Ð¡±à Ãâ·ÑöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2014-03-202013öλÔÓéÀÖ¹Ù·½appÏÂÔØÉúÎïѧöλÔÓéÀֵǼÈë¿ÚÏÂÔØÔºÐ£Ñ¡ÔñÖ¸ÄÏ Î¢ÉúÎï¡¢ÉúÎﻯѧÓë·Ö×ÓÉúÎïѧ
¡¡Ò»¡¢ÉúÎïѧ¾Íҵǰ¾°¡¡¡¡¶ÔÓÚĿǰÉúÎïÀàöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£¬¾Íҵʵ¼ÊÇé¿ö»¹Êǿɹ۵ġ£Î¢ÉúÎï¡¢ÉúÎﻯѧÓë·Ö×ÓÉúÎïѧÈýöλÔÓéÀֵǼÈë¿ÚÏÂÔØµÄĿǰ¾ÍÒµ·½ÏòÓÐÈç ...öλÔÓéÀֵǼÈë¿ÚÏÂÔØ¿ÎöλÔÓéÀÖ¹Ù·½appÏÂÔØ¾Ñé º£ÎĽÌÓý Ãâ·ÑöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2014-01-21ÉúÎﻯѧÓë·Ö×ÓÉúÎïѧöλÔÓéÀֵǼÈë¿ÚÏÂÔØÑо¿ÉúÕÐÉúµ¥Î»
ѧ¿ÆÃÅÀࣺ07 Àíѧһ¼¶Ñ§¿Æ£º0710 ÉúÎïѧöλÔÓéÀֵǼÈë¿ÚÏÂÔØÃû³Æ£º071010 ÉúÎﻯѧÓë·Ö×ÓÉúÎïѧ±±¾©£º(10001)±±¾©´óѧ (10004)±±¾©½»Í¨ ...öλÔÓéÀÖ¹Ù·½appÏÂÔØ±¨¿¼ÐÅÏ¢ öλÔÓéÀÖ¹Ù·½appÏÂÔØÂÛ̳ Ãâ·ÑöλÔÓéÀÖ¹Ù·½appÏÂÔØÂÛ̳ 2010-06-15
